,,ii  #aafth ,,congress  #ast ,session  
,s4 #aadj  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,april #aa1    
#bjai,ms4 ,smith 7for herself and ,mr4  
,cassidy7 introduced the following bill2
 which was read twice and referred to   
the ,committee on ,health1 ,education1  
,labor1 and ,pensions  ,a ,,bill  ,to   
amend the ,public ,health ,service ,act 
with respect to the treatment under     
section #cea7k77#g7 of such ,act        
7relating to exclusivity for reference  
products7 of certain products deemed to 
have a biological product license       
pursuant to section #gjjb of the        
,biologics ,price ,competition and      
,innovation ,act of #bjji4  #a4 ,short  
title ,this ,act may be cited as the    
,protecting ,access to ,biosimilars ,act
 of #bjai4  #b4 ,treatment of biological
 products deemed licensed ,section      
#cea7k77#g7 of the ,public ,health      
,service ,act 7#db ,u4,s4,c4            
#bfb7k77#g77 is amended by adding at the
 end the following3  7,d7 ,deemed       

licenses  7i7 ,no additional exclusivity
 through deeming ,an approved           
application that is deemed to be a      
license for a biological product under  
this section pursuant to section        
#gjjb7;e77#d7 of the ,biologics ,price  
,competition and ,innovation ,act of    
#bjji shall not be treated as having    
been first licensed under subsection 7a7
 for purposes of subparagraphs 7,a7 and 
7,b74  7ii7 ,limitation on exclusivity  
applies to any reference product        
,subparagraph 7,c7 shall apply to any   
reference product1 without regard to    
whether-- 7,i7 such product was first   
licensed under subsection 7a72 or       
7,,ii7 the approved application for such
 product was deemed to be a license for 
a biological product as described in    
clause 7i74  4